Stay updated on VS-6766 and Everolimus Clinical Trial

Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VS-6766 and Everolimus Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page metadata revision/version number has been incremented from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:31:17.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a Lancet Oncology publication citation for the VS-6766 study with an erratum. Removed the old revision note and updated the record to revision v3.5.2 (replacing v3.5.0).
    Difference
    0.1%
    Check dated 2026-04-17T02:49:28.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:22:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision history updated: added 'Revision: v3.4.3' and removed 'Revision: v3.4.2'.
    Difference
    0.0%
    Check dated 2026-03-12T02:27:18.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the earlier government funding/operating-status notices (v3.4.1) were removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:30:53.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A government funding notice was added at the top of the page stating potential delays and that the NIH Clinical Center is open. The recruitment status indicator 'Active, not recruiting' was removed, and the page includes a revision notice (Revision: v3.4.1) with updated dates in January 2026.
    Difference
    0.9%
    Check dated 2026-02-04T06:51:31.000Z thumbnail image

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.